Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot
- PMID: 7856933
Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot
Abstract
The aim of the study was to examine the sensitivity and the specificity of a HIV-1/HIV-2 third-generation enzyme immunoassay, the Abbott recombinant HIV-1/HIV-2 third-generation enzyme immunoassay, which is reported to detect simultaneously IgG and IgM. Sensitivity was evaluated with sera from seropositive subjects and a series of samples from eight HIV-1 seroconverting subjects. Results were compared with Western blot, second-generation immunoassays (including Vidas HIV-1 + 2) and an HIV-1 antigen assay. Specificity was studied with sera collected from a low-risk population and sera with false-reactive enzyme immunoassays results. In seven cases, the third-generation immunoassay detected HIV-antibodies several days earlier (range 4 to > or = 9 days) than the Western blot test according to the criteria proposed by the Association of State and Territorial Public Health Laboratory Directors, ie, positive with two of the three bands-gp160 or gp120, gp41, and p24. In the last case detection occurred at the same time as Western blot. The second-generation tests generally detected HIV-antibodies at the same time as Western blot. Antigaenemia was positive in the first samples tested in most cases, prior to or simultaneously with the Abbott third-generation test first reactivity, before the second generation tests and the Western blot test. In most cases, the disappearance of detectable HIV antigen was observed, and was concurrent with the development of the antibodies immune response. For our low-risk population, the current third-generation EIA test obtained a false-reactive rate of 0.26%. Our data indicate that the Abbott third-generation immunoassay is more sensitive than the Western blot test and the second-generation tests. The addition of a third-generation assay to the strategy for HIV-antibody screening may indeed be of interest and could make it possible to decrease the number of false-negative results.
Similar articles
-
More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.J Clin Lab Anal. 1997;11(5):267-86. doi: 10.1002/(SICI)1098-2825(1997)11:5<267::AID-JCLA5>3.0.CO;2-4. J Clin Lab Anal. 1997. PMID: 9292394 Free PMC article. Review.
-
[Could saliva be used to detect HIV seroconversion?].Sante. 1997 Sep-Oct;7(5):303-7. Sante. 1997. PMID: 9480036 French.
-
[Early diagnosis of primary HIV infections: using a combined screening test (p24 antigen and anti-HIV antibodies)].Schweiz Med Wochenschr. 1999 Feb 27;129(8):319-22. Schweiz Med Wochenschr. 1999. PMID: 10189669 German.
-
Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.J Virol Methods. 2006 Apr;133(1):20-6. doi: 10.1016/j.jviromet.2005.10.013. Epub 2005 Nov 28. J Virol Methods. 2006. PMID: 16313975
-
Status of current clinical tests for human immunodeficiency virus (HIV): applications and limitations.Ann Clin Lab Sci. 1987 Sep-Oct;17(5):279-85. Ann Clin Lab Sci. 1987. PMID: 3314657 Review.
Cited by
-
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.Public Health Rep. 2013 Jul;128(4):247-343. doi: 10.1177/003335491312800403. Public Health Rep. 2013. PMID: 23814319 Free PMC article. No abstract available.
-
Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.J Clin Microbiol. 2009 Aug;47(8):2639-42. doi: 10.1128/JCM.00119-09. Epub 2009 Jun 17. J Clin Microbiol. 2009. PMID: 19535523 Free PMC article.
-
Immune complex transfer enzyme immunoassay that is more sensitive and specific than western blotting for detection of antibody immunoglobulin G to human immunodeficiency virus type 1 in serum with recombinant pol and gag proteins as antigens.Clin Diagn Lab Immunol. 1995 Sep;2(5):535-41. doi: 10.1128/cdli.2.5.535-541.1995. Clin Diagn Lab Immunol. 1995. PMID: 8548531 Free PMC article.
-
More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.J Clin Lab Anal. 1997;11(5):267-86. doi: 10.1002/(SICI)1098-2825(1997)11:5<267::AID-JCLA5>3.0.CO;2-4. J Clin Lab Anal. 1997. PMID: 9292394 Free PMC article. Review.
-
Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.J Clin Virol. 2013 Dec;58 Suppl 1(Suppl 1):e8-e12. doi: 10.1016/j.jcv.2013.09.002. Epub 2013 Sep 12. J Clin Virol. 2013. PMID: 24342483 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical